The ABDA/KBV model - an example of national policies related to community pharmacist interventions to improve medication adherence
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Presentation
- By: GRIESE, Nina (ABDA, Department of Medicine, Berlin, Germany)
Drug-related problems (DRP) and particularly non-adherence as a result of polypharmacy are compromising positive patient outcomes of pharmacotherapy and are main causes of adverse drug events (ADE). They are also causes for higher costs as a result of increased hospital and long-term care admissions, physician visits, as well as further diagnostic.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.